Semaglutide vs Mounjaro | Weight Loss & Diabetes Comparison

ByDr. Moxit Shah

Type 2 Diabetes and excess weight are common metabolic conditions in India. Semaglutide and Mounjaro (tirzepatide) are important medicines used in appropriate patients for Diabetes and, depending on the formulation and indication, Weight Management. Many patients ask how these medicines differ, what the evidence shows and how treatment is selected.

Dr. Moxit Shah, DM Endocrinology, provides specialist care in Ahmedabad for Diabetes, Weight Loss and other endocrine conditions, including medically supervised GLP-1 treatment when appropriate.

What Is Semaglutide?

Semaglutide is a once-weekly injection used for:

  • Type 2 diabetes
  • Weight loss
  • Chronic Weight Management in appropriate formulations and eligible patients

It belongs to the GLP-1 receptor agonist class. It works by:

  • Reducing appetite
  • Slowing stomach emptying
  • Improving insulin release
  • Reducing cravings
  • Helping patients feel full longer

Common brand names include:

  • Ozempic
  • Wegovy

What Is Mounjaro?

Mounjaro contains tirzepatide, a newer once-weekly injection.

Unlike semaglutide, Mounjaro acts on two hormones:

  1. GLP-1
  2. GIP (Glucose-dependent insulinotropic polypeptide)

Because of this dual action, Mounjaro may provide:

  • Greater weight loss
  • Better diabetes control
  • Improved appetite suppression in some patients

Semaglutide vs Mounjaro: Key Differences

FeatureSemaglutideMounjaro
Main IngredientSemaglutideTirzepatide
Hormone ActionGLP-1 onlyGLP-1 + GIP
FrequencyOnce weeklyOnce weekly
Weight LossSignificantOften greater
Diabetes ControlExcellentExcellent to superior
Appetite SuppressionStrongVery strong
Nausea RiskCommon initiallyCommon initially
CostUsually lowerUsually higher
AvailabilityWidely availableNewer availability

What Does the Head-to-Head Weight Loss Evidence Show?

Clinical studies suggest that Mounjaro may lead to more weight loss compared to semaglutide in many patients.

In SURMOUNT-5, a direct 72-week comparison in adults with obesity without Type 2 Diabetes, mean weight change was approximately −20.2% with tirzepatide versus −13.7% with semaglutide. These are trial averages, not guarantees for an individual patient. citeturn1search1

  • Semaglutide: around 10–15% body weight
  • Mounjaro: around 15–22% body weight in some studies

However, results vary depending on:

  • Diet
  • Exercise
  • Sleep
  • PCOS
  • Thyroid issues
  • Insulin resistance
  • Lifestyle habits

Weight loss treatment should always be individualized.

What Does the Diabetes Evidence Show?

Both medicines are highly effective for type 2 diabetes.

Benefits include:

  • Lower HbA1c
  • Better fasting sugar
  • Reduced appetite
  • Weight reduction
  • Lower insulin resistance

In SURPASS-2, tirzepatide produced greater average HbA1c and body-weight reductions than semaglutide 1 mg at 40 weeks in adults with Type 2 Diabetes receiving metformin. citeturn1search2

Common Side Effects

Both injections can cause gastrointestinal side effects, especially during the first few weeks.

Common side effects include:

  • Nausea
  • Vomiting
  • Acidity
  • Constipation
  • Loose motions
  • Bloating
  • Reduced appetite

Most side effects improve gradually after dose adjustment.

Who Should Avoid These Medicines?

These injections may not be suitable for everyone.

Patients should consult an endocrinologist if they have:

  • Severe gastric problems
  • Pancreatitis history
  • Certain thyroid cancers
  • Pregnancy
  • Severe kidney disease

Medical supervision is important before starting any GLP-1 or dual agonist therapy.

How Is the Treatment Choice Made?

Treatment selection depends on:

  • BMI
  • Diabetes status
  • Eating behavior
  • Fatty liver
  • PCOS
  • Thyroid disorders
  • Budget
  • Previous medication response

Some patients respond extremely well to semaglutide, while others may benefit more from Mounjaro.

Lifestyle Still Matters

Even the best weight loss injections work best with:

  • High-protein diet
  • Regular exercise
  • Good sleep
  • Stress management
  • Reduced processed food intake

Medicines are one part of a broader Weight Loss plan and work alongside nutrition, physical activity and appropriate medical follow-up.

Practical Summary

Both Semaglutide and Mounjaro are major advances in obesity and diabetes treatment.

Semaglutide is highly effective and widely trusted, while Mounjaro may provide greater weight loss and stronger metabolic benefits in selected patients.

Choosing the right treatment requires proper medical evaluation, lifestyle assessment, and long-term follow-up.

For expert obesity, diabetes, thyroid, and hormonal treatment guidance, consult Dr. Moxit Shah.

Similar Posts